Abstract

Background: The association between patent foramen ovale (PFO) and migraine has been reported. However, whether transcatheter PFO closure is effective in alleviating migraine remains controversial. The objective of this study was to investigate the efficacy of PFO closure in alleviating migraine in a 5-year follow-up.Methods: Migraineurs with PFO from 2013 to 2015 were included and divided into PFO closure group and non-PFO closure group according to their therapy. Contrast-enhanced transcranial Doppler (c-TCD) was performed to evaluate the degree of the right-to-left shunt (RLS), and headache impact test (HIT-6) questionnaire was administered to assess the disability of migraine at 1- and 5-year follow-up.Results: Of 192 patients, 91 patients underwent PFO closure, and 101 patients refused. The HIT-6 scores of patients in the PFO closure group were significantly lower than those of the non-PFO closure group at both 1- and 5-year follow-up. These results were more pronounced in patients younger than 45 years. Furthermore, in patients with large RLS, the HIT-6 scores of patients in the PFO closure group were significantly lower at both 1- and 5-year follow-up compared with those of the non-PFO closure group. However, in patients with moderate RLS, this difference was significant only at 5-year follow-up.Conclusions: PFO closure is effective in alleviating migraine in the long term. This effect is more obvious when patients are younger than 45 years and RLS is large.

Highlights

  • Migraine is a common disabling neurological disorder characterized by recurrent unilateral, pulsing headache often in association with photophobia, phonophobia, and nausea

  • We retrospectively studied the information of all newly diagnosed migraineurs with right-to-left shunt (RLS) confirmed by contrastenhanced transcranial Doppler (c-TCD) and patent foramen ovale (PFO) confirmed by echocardiography in the Department of Neurology, the First Hospital of Jilin University from January 2013 to January 2015

  • A total of 192 migraineurs with confirmed moderate-to-large RLS caused by PFO were included

Read more

Summary

Introduction

Migraine is a common disabling neurological disorder characterized by recurrent unilateral, pulsing headache often in association with photophobia, phonophobia, and nausea. Over the past several decades, migraine, especially migraine with aura, has been linked with patent foramen ovale (PFO) [4,5,6,7,8]. A multicenter case control study has further confirmed this association between PFO and migraine both with and without aura in the Chinese population [9]. The association between patent foramen ovale (PFO) and migraine has been reported. Whether transcatheter PFO closure is effective in alleviating migraine remains controversial. The objective of this study was to investigate the efficacy of PFO closure in alleviating migraine in a 5-year follow-up

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call